Key result
Combined therapy with steroids and prostaglandin analogues (iloprost) yielded a good clinical response in a patient with cholesterol atheroembolism and organic failure.
Case Report (n=1)
Combined therapy with steroids and iloprost may be a viable therapeutic alternative for cholesterol atheroembolism with organic failure.
Answers are grounded in this paper and cite their sources.
Supports steroid-iloprost use in cholesterol atheroembolism with organ failure; hypothesis-generating and should not yet change practice.
Cholesterol atheroembolism (CAE) is a systemic disorder whose incidence has increased in recent decades and that presents high morbidity and mortality. Although several therapeutic alternatives have been reported, there is no consensus about the best treatment for this disease. In this paper we report the case of a patient with CAE with skin, bowel and kidney involvement who presented a good response to combined therapy with steroids and prostaglandin analogues. Although there are no conclusive studies, we recommend this therapeutic alternative in the management of CAE with organic failure.
No takes yet. Share an insight, caveat, or question.
Sevillano et al. (2012) conducted a case report in Cholesterol atheroembolism (CAE) (n=1). Combined therapy with steroids and iloprost (prostaglandin analogues) was evaluated on Clinical response. Combined therapy with steroids and prostaglandin analogues (iloprost) yielded a good clinical response in a patient with cholesterol atheroembolism and organic failure.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: